Actively Recruiting
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Led by Biohaven Therapeutics Ltd. · Updated on 2026-01-14
550
Participants Needed
15
Research Sites
118 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A study to determine if BHV-8000 is efficacious, safe and tolerable in adults diagnosed with early Parkinson's disease.
CONDITIONS
Official Title
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female participants 40 to 85 years of age, inclusive, at the time of informed consent
- Meet the diagnostic criteria for "Probable PD" as assessed on the Movement Disorder Society Clinical Diagnostic Criteria for PD
- Have a clinician-documented diagnosis of idiopathic Parkinson's disease with onset within 2 years of the Screening Visit
You will not qualify if you...
- Medical history indicating a Parkinsonian syndrome other than idiopathic Parkinson's disease, including progressive supranuclear gaze palsy, multiple system atrophy, drug-induced Parkinsonism, essential tremor, or primary dystonia
- Diagnosis of clinically significant central nervous system disease other than Parkinson's disease
- Current smokers of any form, including tobacco smoke and electronic cigarettes
- Treatment with Parkinson's disease medication(s)
- Any other condition that may compromise participant safety, interfere with study conduct, or affect interpretation of study results, as judged by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 15 locations
1
Site-049
Birmingham, Alabama, United States, 35294
Actively Recruiting
2
Site-041
Los Angeles, California, United States, 90033
Actively Recruiting
3
Site-031
Farmington, Connecticut, United States, 06030
Actively Recruiting
4
Site-028
New Haven, Connecticut, United States, 06510
Actively Recruiting
5
Site-038
Atlantis, Florida, United States, 33462
Actively Recruiting
6
Site-017
Boca Raton, Florida, United States, 33486
Actively Recruiting
7
Site-051
Maitland, Florida, United States, 32751
Actively Recruiting
8
Site-027
Chicago, Illinois, United States, 60611
Actively Recruiting
9
Site-071
Boston, Massachusetts, United States, 02114
Actively Recruiting
10
Site-015
Farmington Hills, Michigan, United States, 48334
Actively Recruiting
11
Site-044
Chesterfield, Missouri, United States, 63005
Actively Recruiting
12
Site-005
New York, New York, United States, 10021
Actively Recruiting
13
Site-091
Portland, Oregon, United States, 97210
Actively Recruiting
14
Site-043
Round Rock, Texas, United States, 78681
Actively Recruiting
15
Site-007
Bellevue, Washington, United States, 98007
Actively Recruiting
Research Team
C
Chief Medical Officer
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here